Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,084 public trials 2,045 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

Fludarabine in Treating Patients With Chronic Lymphocytic Leukemia

NCT00049075

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +13 more
Locations
  • Tom Baker Cancer Center - Calgary Calgary, Alberta, Canada
  • Cross Cancer Institute Edmonton, Alberta, Canada
  • Providence Health Care - Vancouver Vancouver, British Columbia, Canada
  • CancerCare Manitoba Winnipeg, Manitoba, Canada
View all 34 locations
View Trial Details
Completed

Zoledronic Acid in Patients With Multiple Myeloma and Asymptomatic Biochemical Relapse

NCT01087008

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Hospital Universitari Germans Trias I Pujol Badalona, Spain
  • Hospital de la Santa Creu i Sant Pau Barcelona, Spain
  • Hospital del Mar Barcelona, Spain
  • Hospital Vall d'Hebrón Barcelona, Spain
View all 16 locations
View Trial Details
Completed

Treatment for Chronic Pain in Patients With Advanced Cancer

NCT00003687

Conditions
Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +93 more
Locations
  • Cross Cancer Institute Edmonton, Alberta, Canada
  • Newfoundland Cancer Treatment and Research Foundation St. John's, Newfoundland and Labrador, Canada
  • Princess Margaret Hospital Toronto, Ontario, Canada
  • McGill University Montreal, Quebec, Canada
View Trial Details
Completed

Thalidomide and Prednisone Following Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma

NCT00006890

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • St. Mary's/Duluth Clinic Health System Duluth, Minnesota, United States
  • Tom Baker Cancer Center - Calgary Calgary, Alberta, Canada
  • Lethbridge Cancer Clinic Lethbridge, Alberta, Canada
  • Burnaby Hospital Regional Cancer Centre Burnaby, British Columbia, Canada
View all 64 locations
View Trial Details
Completed

Combination Chemotherapy in Treating Patients With Multiple Myeloma

NCT00002678

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • St. Mary's/Duluth Clinic Health System Duluth, Minnesota, United States
  • Tom Baker Cancer Center - Calgary Calgary, Alberta, Canada
  • Cross Cancer Institute Edmonton, Alberta, Canada
  • British Columbia Cancer Agency - Centre for the Southern Interior Kelowna, British Columbia, Canada
View all 37 locations
View Trial Details
Completed

Radiation Therapy in Relapsed or Refractory Non-Hodgkin's Lymphoma Who Have Undergone Stem Cell Transplantation

NCT00031668

Conditions
Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +30 more
Locations
  • Tom Baker Cancer Center - Calgary Calgary, Alberta, Canada
  • Cross Cancer Institute Edmonton, Alberta, Canada
  • Newfoundland Cancer Treatment and Research Foundation St. John's, Newfoundland and Labrador, Canada
  • Cancer Care Ontario-Hamilton Regional Cancer Centre Hamilton, Ontario, Canada
View Trial Details
Completed

Study of Oral Ixazomib in Adult Participants With Relapsed or Refractory Light Chain Amyloidosis

NCT01318902

Conditions
Amyloidosis, Immune System Diseases, Immunoglobulin Light-chain Amyloidosis, +10 more
Locations
  • Tufts Medical Center Boston, Massachusetts, United States
  • Boston Medical Center Boston, Massachusetts, United States
  • Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
  • Mayo Clinic Rochester, Minnesota, United States
View Trial Details
Completed

Combination Chemotherapy With or Without Rituximab in Non-Hodgkin's Lymphoma

NCT00064116

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Tom Baker Cancer Centre Calgary, Alberta, Canada
  • Cross Cancer Institute Edmonton, Alberta, Canada
  • CancerCare Manitoba Winnipeg, Manitoba, Canada
  • The Moncton Hospital Moncton, New Brunswick, Canada
View all 25 locations
View Trial Details

Related conditions